APO Research
Talk to an analyst

APO RESEARCH · REPORT

ADC Drug CDMO Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global ADC Drug CDMO Service Industry Growth and Trends Forecast to 2032

5 June 2026114 pages

Choose your research edition.

Industry ResearchADC Drug CDMO Service Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal ADC Drug CDMO Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal ADC Drug CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ADC Drug CDMO Service Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal ADC Drug CDMO Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global ADC Drug CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for ADC Drug CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for ADC Drug CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for ADC Drug CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the ADC Drug CDMO Service market include Lonza Group, Merck KGaA, WuXi XDC, Abbvie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions, Axplora and Aji Bio-Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global ADC Drug CDMO Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The ADC Drug CDMO Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global ADC Drug CDMO Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to ADC Drug CDMO Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global ADC Drug CDMO Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

ADC Drug CDMO Service Market by Company

Lonza Group

Merck KGaA

WuXi XDC

Abbvie

Piramal Pharma Solutions

Catalent

Sterling Pharma Solutions

Axplora

Aji Bio-Pharma

BSP Pharmaceuticals

Cerbios-Pharma

Goodwin Biotechnology

TOT Biopharm

Huadong Medicine

Innovent Biologics

Shanghai Henlius Biotech

ADC Drug CDMO Service Segment by Type

Cleavable Linkers

Non-cleavable Linkers

ADC Drug CDMO Service Segment by Application

Small and Medium-sized Pharmaceutical Companies

Large Pharmaceutical Companies

ADC Drug CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ADC Drug CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ADC Drug CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ADC Drug CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of ADC Drug CDMO Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global ADC Drug CDMO Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global ADC Drug CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global ADC Drug CDMO Service Market Share by Region (2021-2026) Table 4. Global ADC Drug CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global ADC Drug CDMO Service Market Share by Region (2027-2032) Table 6. Global ADC Drug CDMO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global ADC Drug CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global ADC Drug CDMO Service Market Size Share by Type (2021-2026) Table 9. Global ADC Drug CDMO Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global ADC Drug CDMO Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America ADC Drug CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe ADC Drug CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific ADC Drug CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America ADC Drug CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa ADC Drug CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global ADC Drug CDMO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global ADC Drug CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global ADC Drug CDMO Service Market Size Share by Application (2021-2026) Table 24. Global ADC Drug CDMO Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global ADC Drug CDMO Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America ADC Drug CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe ADC Drug CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific ADC Drug CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America ADC Drug CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa ADC Drug CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. ADC Drug CDMO Service Industry Trends Table 37. ADC Drug CDMO Service Industry Drivers Table 38. ADC Drug CDMO Service Industry Opportunities and Challenges Table 39. ADC Drug CDMO Service Industry Restraints Table 40. Global ADC Drug CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global ADC Drug CDMO Service Revenue Market Share by Company (2021-2026) Table 42. Global ADC Drug CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global ADC Drug CDMO Service Key Company Headquarters & Area Served Table 44. Global ADC Drug CDMO Service Company, Product Type & Application Table 45. Global ADC Drug CDMO Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global ADC Drug CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lonza Group Company Information Table 49. Lonza Group Business Overview Table 50. Lonza Group ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lonza Group ADC Drug CDMO Service Product Portfolio Table 52. Lonza Group Recent Development Table 53. Merck KGaA Company Information Table 54. Merck KGaA Business Overview Table 55. Merck KGaA ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Merck KGaA ADC Drug CDMO Service Product Portfolio Table 57. Merck KGaA Recent Development Table 58. WuXi XDC Company Information Table 59. WuXi XDC Business Overview Table 60. WuXi XDC ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. WuXi XDC ADC Drug CDMO Service Product Portfolio Table 62. WuXi XDC Recent Development Table 63. Abbvie Company Information Table 64. Abbvie Business Overview Table 65. Abbvie ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Abbvie ADC Drug CDMO Service Product Portfolio Table 67. Abbvie Recent Development Table 68. Piramal Pharma Solutions Company Information Table 69. Piramal Pharma Solutions Business Overview Table 70. Piramal Pharma Solutions ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Piramal Pharma Solutions ADC Drug CDMO Service Product Portfolio Table 72. Piramal Pharma Solutions Recent Development Table 73. Catalent Company Information Table 74. Catalent Business Overview Table 75. Catalent ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Catalent ADC Drug CDMO Service Product Portfolio Table 77. Catalent Recent Development Table 78. Sterling Pharma Solutions Company Information Table 79. Sterling Pharma Solutions Business Overview Table 80. Sterling Pharma Solutions ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Sterling Pharma Solutions ADC Drug CDMO Service Product Portfolio Table 82. Sterling Pharma Solutions Recent Development Table 83. Axplora Company Information Table 84. Axplora Business Overview Table 85. Axplora ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Axplora ADC Drug CDMO Service Product Portfolio Table 87. Axplora Recent Development Table 88. Aji Bio-Pharma Company Information Table 89. Aji Bio-Pharma Business Overview Table 90. Aji Bio-Pharma ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Aji Bio-Pharma ADC Drug CDMO Service Product Portfolio Table 92. Aji Bio-Pharma Recent Development Table 93. BSP Pharmaceuticals Company Information Table 94. BSP Pharmaceuticals Business Overview Table 95. BSP Pharmaceuticals ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. BSP Pharmaceuticals ADC Drug CDMO Service Product Portfolio Table 97. BSP Pharmaceuticals Recent Development Table 98. Cerbios-Pharma Company Information Table 99. Cerbios-Pharma Business Overview Table 100. Cerbios-Pharma ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Cerbios-Pharma ADC Drug CDMO Service Product Portfolio Table 102. Cerbios-Pharma Recent Development Table 103. Goodwin Biotechnology Company Information Table 104. Goodwin Biotechnology Business Overview Table 105. Goodwin Biotechnology ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Goodwin Biotechnology ADC Drug CDMO Service Product Portfolio Table 107. Goodwin Biotechnology Recent Development Table 108. TOT Biopharm Company Information Table 109. TOT Biopharm Business Overview Table 110. TOT Biopharm ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. TOT Biopharm ADC Drug CDMO Service Product Portfolio Table 112. TOT Biopharm Recent Development Table 113. Huadong Medicine Company Information Table 114. Huadong Medicine Business Overview Table 115. Huadong Medicine ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Huadong Medicine ADC Drug CDMO Service Product Portfolio Table 117. Huadong Medicine Recent Development Table 118. Innovent Biologics Company Information Table 119. Innovent Biologics Business Overview Table 120. Innovent Biologics ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Innovent Biologics ADC Drug CDMO Service Product Portfolio Table 122. Innovent Biologics Recent Development Table 123. Shanghai Henlius Biotech Company Information Table 124. Shanghai Henlius Biotech Business Overview Table 125. Shanghai Henlius Biotech ADC Drug CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Shanghai Henlius Biotech ADC Drug CDMO Service Product Portfolio Table 127. Shanghai Henlius Biotech Recent Development Table 128. North America ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America ADC Drug CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 130. North America ADC Drug CDMO Service Market Share by Country (2021-2026) Table 131. North America ADC Drug CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America ADC Drug CDMO Service Market Share Forecast by Country (2027-2032) Table 133. Europe ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe ADC Drug CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe ADC Drug CDMO Service Market Share by Country (2021-2026) Table 136. Europe ADC Drug CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe ADC Drug CDMO Service Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific ADC Drug CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific ADC Drug CDMO Service Market Share by Country (2021-2026) Table 141. Asia-Pacific ADC Drug CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific ADC Drug CDMO Service Market Share Forecast by Country (2027-2032) Table 143. Latin America ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America ADC Drug CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America ADC Drug CDMO Service Market Share by Country (2021-2026) Table 146. Latin America ADC Drug CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America ADC Drug CDMO Service Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa ADC Drug CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa ADC Drug CDMO Service Market Share by Country (2021-2026) Table 151. Middle East & Africa ADC Drug CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa ADC Drug CDMO Service Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. ADC Drug CDMO Service Product Image Figure 3. Global ADC Drug CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global ADC Drug CDMO Service Market Size (2021-2032) & (US$ Million) Figure 5. Global ADC Drug CDMO Service Market Share by Region: 2025 VS 2032 Figure 6. Global ADC Drug CDMO Service Market Share by Region (2021-2032) Figure 7. North America ADC Drug CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe ADC Drug CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific ADC Drug CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America ADC Drug CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa ADC Drug CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cleavable Linkers Image Figure 13. Global Cleavable Linkers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Non-cleavable Linkers Image Figure 15. Global Non-cleavable Linkers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global ADC Drug CDMO Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global ADC Drug CDMO Service Market Share by Type 2025 VS 2032 Figure 18. North America ADC Drug CDMO Service Market Size Share by Type (2021-2032) Figure 19. Europe ADC Drug CDMO Service Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific ADC Drug CDMO Service Market Size Share by Type (2021-2032) Figure 21. Latin America ADC Drug CDMO Service Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa ADC Drug CDMO Service Market Size Share by Type (2021-2032) Figure 23. Small and Medium-sized Pharmaceutical Companies Image Figure 24. Global Small and Medium-sized Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Large Pharmaceutical Companies Image Figure 26. Global Large Pharmaceutical Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global ADC Drug CDMO Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global ADC Drug CDMO Service Market Share by Application 2025 VS 2032 Figure 29. North America ADC Drug CDMO Service Market Size Share by Application (2021-2032) Figure 30. Europe ADC Drug CDMO Service Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific ADC Drug CDMO Service Market Size Share by Application (2021-2032) Figure 32. Latin America ADC Drug CDMO Service Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa ADC Drug CDMO Service Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 ADC Drug CDMO Service Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America ADC Drug CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America ADC Drug CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America ADC Drug CDMO Service Market Share by Country (2021-2032) Figure 39. Europe ADC Drug CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe ADC Drug CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe ADC Drug CDMO Service Market Share by Country (2021-2032) Figure 42. Asia-Pacific ADC Drug CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific ADC Drug CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific ADC Drug CDMO Service Market Share by Country (2021-2032) Figure 45. Latin America ADC Drug CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America ADC Drug CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America ADC Drug CDMO Service Market Share by Country (2021-2032) Figure 48. Middle East & Africa ADC Drug CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa ADC Drug CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa ADC Drug CDMO Service Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Cleavable Linkers
  • Non-cleavable Linkers
Applications
  • Small and Medium-sized Pharmaceutical Companies
  • Large Pharmaceutical Companies
Companies covered
  • Lonza Group
  • Merck KGaA
  • WuXi XDC
  • Abbvie
  • Piramal Pharma Solutions
  • Catalent
  • Sterling Pharma Solutions
  • Axplora
  • Aji Bio-Pharma
  • BSP Pharmaceuticals
  • Cerbios-Pharma
  • Goodwin Biotechnology
  • TOT Biopharm
  • Huadong Medicine
  • Innovent Biologics
  • Shanghai Henlius Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global ADC Drug CDMO Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global ADC Drug CDMO Service Market Size by Region (2021-2032)
  5. 1.4.1 Global ADC Drug CDMO Service Market Size by Region (2021-2026)
  6. 1.4.2 Global ADC Drug CDMO Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions ADC Drug CDMO Service Market Size (2021-2032)
  8. 1.5.1 North America ADC Drug CDMO Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe ADC Drug CDMO Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific ADC Drug CDMO Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America ADC Drug CDMO Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa ADC Drug CDMO Service Market Size Growth Rate (2021-2032)
2 ADC Drug CDMO Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cleavable Linkers
  3. 2.1.2 Non-cleavable Linkers
  4. 2.2 Global ADC Drug CDMO Service Market Size by Type
  5. 2.2.1 Global ADC Drug CDMO Service Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global ADC Drug CDMO Service Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global ADC Drug CDMO Service Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global ADC Drug CDMO Service Market Size by Regions
  9. 2.3.1 North America ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa ADC Drug CDMO Service Market Size Breakdown by Type (2021-2026)
3 ADC Drug CDMO Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Small and Medium-sized Pharmaceutical Companies
  3. 3.1.2 Large Pharmaceutical Companies
  4. 3.2 Global ADC Drug CDMO Service Market Size by Application
  5. 3.2.1 Global ADC Drug CDMO Service Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global ADC Drug CDMO Service Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global ADC Drug CDMO Service Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global ADC Drug CDMO Service Market Size by Regions
  9. 3.3.1 North America ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa ADC Drug CDMO Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 ADC Drug CDMO Service Industry Trends
  2. 4.2 ADC Drug CDMO Service Industry Drivers
  3. 4.3 ADC Drug CDMO Service Industry Opportunities and Challenges
  4. 4.4 ADC Drug CDMO Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by ADC Drug CDMO Service Revenue (2021-2026)
  2. 5.2 Global ADC Drug CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global ADC Drug CDMO Service Key Company Headquarters & Area Served
  4. 5.4 Global ADC Drug CDMO Service Company, Product Type & Application
  5. 5.5 Global ADC Drug CDMO Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global ADC Drug CDMO Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 ADC Drug CDMO Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 ADC Drug CDMO Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lonza Group
  2. 6.1.1 Lonza Group Company Information
  3. 6.1.2 Lonza Group Business Overview
  4. 6.1.3 Lonza Group ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lonza Group ADC Drug CDMO Service Product Portfolio
  6. 6.1.5 Lonza Group Recent Developments
  7. 6.2 Merck KGaA
  8. 6.2.1 Merck KGaA Company Information
  9. 6.2.2 Merck KGaA Business Overview
  10. 6.2.3 Merck KGaA ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Merck KGaA ADC Drug CDMO Service Product Portfolio
  12. 6.2.5 Merck KGaA Recent Developments
  13. 6.3 WuXi XDC
  14. 6.3.1 WuXi XDC Company Information
  15. 6.3.2 WuXi XDC Business Overview
  16. 6.3.3 WuXi XDC ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 WuXi XDC ADC Drug CDMO Service Product Portfolio
  18. 6.3.5 WuXi XDC Recent Developments
  19. 6.4 Abbvie
  20. 6.4.1 Abbvie Company Information
  21. 6.4.2 Abbvie Business Overview
  22. 6.4.3 Abbvie ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Abbvie ADC Drug CDMO Service Product Portfolio
  24. 6.4.5 Abbvie Recent Developments
  25. 6.5 Piramal Pharma Solutions
  26. 6.5.1 Piramal Pharma Solutions Company Information
  27. 6.5.2 Piramal Pharma Solutions Business Overview
  28. 6.5.3 Piramal Pharma Solutions ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Piramal Pharma Solutions ADC Drug CDMO Service Product Portfolio
  30. 6.5.5 Piramal Pharma Solutions Recent Developments
  31. 6.6 Catalent
  32. 6.6.1 Catalent Company Information
  33. 6.6.2 Catalent Business Overview
  34. 6.6.3 Catalent ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Catalent ADC Drug CDMO Service Product Portfolio
  36. 6.6.5 Catalent Recent Developments
  37. 6.7 Sterling Pharma Solutions
  38. 6.7.1 Sterling Pharma Solutions Company Information
  39. 6.7.2 Sterling Pharma Solutions Business Overview
  40. 6.7.3 Sterling Pharma Solutions ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Sterling Pharma Solutions ADC Drug CDMO Service Product Portfolio
  42. 6.7.5 Sterling Pharma Solutions Recent Developments
  43. 6.8 Axplora
  44. 6.8.1 Axplora Company Information
  45. 6.8.2 Axplora Business Overview
  46. 6.8.3 Axplora ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Axplora ADC Drug CDMO Service Product Portfolio
  48. 6.8.5 Axplora Recent Developments
  49. 6.9 Aji Bio-Pharma
  50. 6.9.1 Aji Bio-Pharma Company Information
  51. 6.9.2 Aji Bio-Pharma Business Overview
  52. 6.9.3 Aji Bio-Pharma ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Aji Bio-Pharma ADC Drug CDMO Service Product Portfolio
  54. 6.9.5 Aji Bio-Pharma Recent Developments
  55. 6.10 BSP Pharmaceuticals
  56. 6.10.1 BSP Pharmaceuticals Company Information
  57. 6.10.2 BSP Pharmaceuticals Business Overview
  58. 6.10.3 BSP Pharmaceuticals ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 BSP Pharmaceuticals ADC Drug CDMO Service Product Portfolio
  60. 6.10.5 BSP Pharmaceuticals Recent Developments
  61. 6.11 Cerbios-Pharma
  62. 6.11.1 Cerbios-Pharma Company Information
  63. 6.11.2 Cerbios-Pharma Business Overview
  64. 6.11.3 Cerbios-Pharma ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Cerbios-Pharma ADC Drug CDMO Service Product Portfolio
  66. 6.11.5 Cerbios-Pharma Recent Developments
  67. 6.12 Goodwin Biotechnology
  68. 6.12.1 Goodwin Biotechnology Company Information
  69. 6.12.2 Goodwin Biotechnology Business Overview
  70. 6.12.3 Goodwin Biotechnology ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Goodwin Biotechnology ADC Drug CDMO Service Product Portfolio
  72. 6.12.5 Goodwin Biotechnology Recent Developments
  73. 6.13 TOT Biopharm
  74. 6.13.1 TOT Biopharm Company Information
  75. 6.13.2 TOT Biopharm Business Overview
  76. 6.13.3 TOT Biopharm ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 TOT Biopharm ADC Drug CDMO Service Product Portfolio
  78. 6.13.5 TOT Biopharm Recent Developments
  79. 6.14 Huadong Medicine
  80. 6.14.1 Huadong Medicine Company Information
  81. 6.14.2 Huadong Medicine Business Overview
  82. 6.14.3 Huadong Medicine ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Huadong Medicine ADC Drug CDMO Service Product Portfolio
  84. 6.14.5 Huadong Medicine Recent Developments
  85. 6.15 Innovent Biologics
  86. 6.15.1 Innovent Biologics Company Information
  87. 6.15.2 Innovent Biologics Business Overview
  88. 6.15.3 Innovent Biologics ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Innovent Biologics ADC Drug CDMO Service Product Portfolio
  90. 6.15.5 Innovent Biologics Recent Developments
  91. 6.16 Shanghai Henlius Biotech
  92. 6.16.1 Shanghai Henlius Biotech Company Information
  93. 6.16.2 Shanghai Henlius Biotech Business Overview
  94. 6.16.3 Shanghai Henlius Biotech ADC Drug CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Shanghai Henlius Biotech ADC Drug CDMO Service Product Portfolio
  96. 6.16.5 Shanghai Henlius Biotech Recent Developments
7 North America
  1. 7.1 North America ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America ADC Drug CDMO Service Market Size by Country (2021-2026)
  3. 7.3 North America ADC Drug CDMO Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe ADC Drug CDMO Service Market Size by Country (2021-2026)
  3. 8.3 Europe ADC Drug CDMO Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific ADC Drug CDMO Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific ADC Drug CDMO Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America ADC Drug CDMO Service Market Size by Country (2021-2026)
  3. 10.3 South America ADC Drug CDMO Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa ADC Drug CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa ADC Drug CDMO Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa ADC Drug CDMO Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst